Want to see IN:JLHL full AI Analyst Report?
JLHL Stock Chart & Stats
₹1542.60
₹35.65(2.30%)
At close: 4:00 PM EST
₹1542.60
₹35.65(2.30%)
Day’s Range― - ―
52-Week Range₹1,152.05 - ₹1,618.15
Previous CloseN/A
Volume62.45K
Average Volume (3M)947.00
Market Cap
₹95.11B
Enterprise Value₹93.01B
Total Cash (Recent Filing)₹5.64B
Total Debt (Recent Filing)₹4.03B
Price to Earnings (P/E)48.8
Beta0.16
Next Earnings
Oct 02, 2026Next Dividend Ex-DateN/A
Dividend Yield0.14%
Share Statistics
EPS (TTM)30.29
Shares Outstanding65,566,025
10 Day Avg. Volume721
30 Day Avg. Volume947
Financial Highlights & Ratios
PEG Ratio106.33
Price to Book (P/B)5.45
Price to Sales (P/S)5.61
P/FCF Ratio-35.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)34
Revenue Forecast (FY)₹18.15B
Bulls Say, Bears Say
Bulls Say
Consistent Multi-year Revenue GrowthMulti-year top-line scaling (2021–2026) and reported ~18.9% revenue growth indicate durable demand and expanding patient volumes. Sustained revenue growth supports fixed-cost absorption, capacity leverage, and provides a stable base for margin recovery and reinvestment over the next 2–6 months.
Turnaround To Sustained ProfitabilityThe company moved from loss-making in 2021 to consistently positive net income recently, reflecting improved operating performance and earnings quality. Persistent profitability enhances internal capital generation, strengthens stakeholder confidence, and underpins longer-term investment in clinical capabilities and growth.
Improved Leverage And Equity ExpansionA materially improved leverage profile and strong equity expansion reduce financial vulnerability and increase strategic flexibility. A stronger balance sheet supports funding of capacity expansion, hedges against cyclical downturns, and lowers refinancing risk over the medium term.
Bears Say
Sharply Negative Free Cash FlowDespite positive operating cash flow, free cash flow is sharply negative due to heavy capex and/or working-capital absorption. Persistent negative FCF erodes liquidity after reinvestment, forces external financing, and raises execution risk if cash burn continues while expansion ramps.
2026 Margin CompressionCompression across gross, EBIT, and net margins in 2026 suggests rising costs, mix shifts, or ramp-related expenses. If structural, weaker margins could reduce cash generation and returns on invested capital, making future expansion less accretive and amplifying funding needs.
Step-up In Total Debt In 2026An increase in total debt in 2026 offsets some balance-sheet improvements and, combined with negative FCF, raises refinancing and leverage risk. Continued debt accumulation could stress interest coverage and limit financial flexibility for strategic investments or cushion against shocks.
Jupiter Life Line Hospitals Ltd. News
JLHL FAQ
What was Jupiter Life Line Hospitals Ltd.’s price range in the past 12 months?
Jupiter Life Line Hospitals Ltd. lowest stock price was ₹1152.05 and its highest was ₹1618.15 in the past 12 months.
What is Jupiter Life Line Hospitals Ltd.’s market cap?
Jupiter Life Line Hospitals Ltd.’s market cap is ₹95.11B.
When is Jupiter Life Line Hospitals Ltd.’s upcoming earnings report date?
Jupiter Life Line Hospitals Ltd.’s upcoming earnings report date is Oct 02, 2026 which is in 84 days.
How were Jupiter Life Line Hospitals Ltd.’s earnings last quarter?
Jupiter Life Line Hospitals Ltd. released its earnings results on May 15, 2026. The company reported ₹7.5 earnings per share for the quarter, beating the consensus estimate of N/A by ₹7.5.
Is Jupiter Life Line Hospitals Ltd. overvalued?
According to Wall Street analysts Jupiter Life Line Hospitals Ltd.’s price is currently Overvalued.
Does Jupiter Life Line Hospitals Ltd. pay dividends?
Jupiter Life Line Hospitals Ltd. pays a Notavailable dividend of ₹1 which represents an annual dividend yield of 0.14%. See more information on Jupiter Life Line Hospitals Ltd. dividends here
What is Jupiter Life Line Hospitals Ltd.’s EPS estimate?
Jupiter Life Line Hospitals Ltd.’s EPS estimate is 8.
How many shares outstanding does Jupiter Life Line Hospitals Ltd. have?
Jupiter Life Line Hospitals Ltd. has 65,566,025 shares outstanding.
What happened to Jupiter Life Line Hospitals Ltd.’s price movement after its last earnings report?
Jupiter Life Line Hospitals Ltd. reported an EPS of ₹7.5 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.415%.
Which hedge fund is a major shareholder of Jupiter Life Line Hospitals Ltd.?
Currently, no hedge funds are holding shares in IN:JLHL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Jupiter Life Line Hospitals Ltd.
Jupiter Life Line Hospitals Limited, established in Mumbai, India, in 2002, operates as a multi-specialty healthcare provider throughout the country under its Jupiter brand. The company delivers a comprehensive range of medical and surgical services spanning numerous disciplines. These include diverse surgical fields such as bariatric, cardiac, general, minimal access, HPB, surgical gastroenterology, neurosurgery, organ transplant, orthopedics (including robotic knee replacement), and plastic and cosmetic surgery. Additionally, Jupiter Life Line Hospitals offers specialized care in cardiology, chest medicine, dental care, dermatology, ENT, endocrinology and diabetes, gastroenterology, hematology and bone marrow transplantation, infectious diseases, internal medicine, interventional radiology, mental health, nephrology, neurology, nutrition and dietetics, obstetrics and gynecology, oncology, ophthalmology, pediatrics, pain management, rehabilitation, and rheumatology. Beyond its healthcare operations, the company also manages the Fortune Park Lake City Hotel located in Thane.
Technical Analysis
Artemis Medicare Services Ltd.
―
HealthCare Global Enterprises Ltd.
―
Indraprastha Medical Corporation Limited
―
Shalby Ltd.
―
Yatharth Hospital and Trauma Care Services Limited
―